Report Overview
Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Artificial Liver market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Artificial Liver market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Artificial Liver market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Artificial Liver products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Artificial Liver products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Artificial Liver market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Artificial Liver development has been the leading industry trend of Artificial Liver market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Artificial Liver Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Type 1,Type 2,Type 3,Type 4,Type 5 |
| By Application Outlook |
Application 1,Application 2,Application 3,Application 4,Application 5 |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Abbott Diabetes Care, Inc. ,Baxter International, Inc. ,Vital Therapies, Inc. ,Xenios AG,Asahi Kasei Medical Co., Ltd. ,Medtronic, Inc. ,F.Hoffmann-La Roche Ltd.,Fresenius Medical Care AG & Co. KGaA ,HeartWare International, Inc. ,Jarvik Heart, Inc. ,Nikkiso Co., Ltd. ,Nipro Corporation ,SynCardia Systems, Inc. ,Terumo Heart, Inc. ,Thoratec Corp.,Toray Medical Co., Ltd. |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Abbott Diabetes Care
- Inc.
- Baxter International
- Inc.
- Vital Therapies
- Inc.
- Xenios AG
- Asahi Kasei Medical Co.
- Ltd.
- Medtronic
- Inc.
- F.Hoffmann-La Roche Ltd.
- Fresenius Medical Care AG & Co. KGaA
- HeartWare International
- Inc.
- Jarvik Heart
- Inc.
- Nikkiso Co.
- Ltd.
- Nipro Corporation
- SynCardia Systems
- Inc.
- Terumo Heart
- Inc.
- Thoratec Corp.
- Toray Medical Co.
- Ltd.
Artificial Liver Market, By Type
- Type 1
- Type 2
- Type 3
- Type 4
- Type 5
Artificial Liver Market, By Application
- Application 1
- Application 2
- Application 3
- Application 4
- Application 5
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table Of Contents
Table of Contents
Global Artificial Liver Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Artificial Liver Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Product Type Market
2.1 World Product Type Market Performance and Trend
2.1.1 World Market Performance
2.1.2 Different Type of Market Performance
2.2 North America Product Type Market Performance and Trend
2.2.1 North America Market Performance
2.2.2 Different Type of Market Performance
2.3 Europe Product Type Market Performance and Trend
2.3.1 Europe Market Performance
2.3.2 Different Type of Market Performance
2.4 Asia-Pacific Product Type Market Performance and Trend
2.4.1 Asia-Pacific Market Performance
2.4.2 Different Type of Market Performance
2.5 South America Product Type Market Performance and Trend
2.5.1 South America Market Performance
2.5.2 Different Type of Market Performance
2.6 Middle East and Africa Product Type Market Performance and Trend
2.6.1 Middle East and Africa Market Performance
2.6.2 Different Type of Market Performance
3 Product Application Market
3.1 World Product Application Market Performance and Trend
3.1.1 World Market Performance
3.1.2 Different Applications of Market Trend
3.2 North America Product Application Market Performance and Trend
3.2.1 North America Market Performance
3.2.2 Different Applications of Market Trend
3.3 Europe Product Application Market Performance and Trend
3.3.1 Europe Market Performance
3.3.2 Different Applications of Market Trend
3.4 Asia-Pacific Product Application Market Performance and Trend
3.4.1 Asia-Pacific Market Performance
3.4.2 Different Applications of Market Trend
3.5 South America Product Application Market Performance and Trend
3.5.1 South America Market Performance
3.5.2 Different Applications of Market Trend
3.6 Middle East and Africa Product Application Market Performance and Trend
3.6.1 Middle East and Africa Market Performance
3.6.2 Different Applications of Market Trend
4 Manufacturers Profiles/Analysis
4.1 Abbott Diabetes Care, Inc. (USA)
4.1.1 Abbott Diabetes Care, Inc. (USA) Profiles
4.1.2 Abbott Diabetes Care, Inc. (USA) Product Information
4.1.3 Abbott Diabetes Care, Inc. (USA) Artificial Liver Business Performance
4.1.4 Abbott Diabetes Care, Inc. (USA) Artificial Liver Business Development and Market Status
4.2 Baxter International, Inc. (USA)
4.2.1 Baxter International, Inc. (USA) Profiles
4.2.2 Baxter International, Inc. (USA) Product Information
4.2.3 Baxter International, Inc. (USA) Artificial Liver Business Performance
4.2.4 Baxter International, Inc. (USA) Artificial Liver Business Development and Market Status
4.3 Vital Therapies, Inc. (USA)
4.3.1 Vital Therapies, Inc. (USA) Profiles
4.3.2 Vital Therapies, Inc. (USA) Product Information
4.3.3 Vital Therapies, Inc. (USA) Artificial Liver Business Performance
4.3.4 Vital Therapies, Inc. (USA) Artificial Liver Business Development and Market Status
4.4 Xenios AG (Germany)
4.4.1 Xenios AG (Germany) Profiles
4.4.2 Xenios AG (Germany) Product Information
4.4.3 Xenios AG (Germany) Artificial Liver Business Performance
4.4.4 Xenios AG (Germany) Artificial Liver Business Development and Market Status
4.5 Asahi Kasei Medical Co., Ltd. (Japan)
4.5.1 Asahi Kasei Medical Co., Ltd. (Japan) Profiles
4.5.2 Asahi Kasei Medical Co., Ltd. (Japan) Product Information
4.5.3 Asahi Kasei Medical Co., Ltd. (Japan) Artificial Liver Business Performance
4.5.4 Asahi Kasei Medical Co., Ltd. (Japan) Artificial Liver Business Development and Market Status
4.6 Medtronic, Inc. (USA)
4.6.1 Medtronic, Inc. (USA) Profiles
4.6.2 Medtronic, Inc. (USA) Product Information
4.6.3 Medtronic, Inc. (USA) Artificial Liver Business Performance
4.6.4 Medtronic, Inc. (USA) Artificial Liver Business Development and Market Status
4.7 F.Hoffmann-La Roche Ltd. (Switzerland)
4.7.1 F.Hoffmann-La Roche Ltd. (Switzerland) Profiles
4.7.2 F.Hoffmann-La Roche Ltd. (Switzerland) Product Information
4.7.3 F.Hoffmann-La Roche Ltd. (Switzerland) Artificial Liver Business Performance
4.7.4 F.Hoffmann-La Roche Ltd. (Switzerland) Artificial Liver Business Development and Market Status
4.8 Fresenius Medical Care AG & Co. KGaA (Germany)
4.8.1 Fresenius Medical Care AG & Co. KGaA (Germany) Profiles
4.8.2 Fresenius Medical Care AG & Co. KGaA (Germany) Product Information
4.8.3 Fresenius Medical Care AG & Co. KGaA (Germany) Artificial Liver Business Performance
4.8.4 Fresenius Medical Care AG & Co. KGaA (Germany) Artificial Liver Business Development and Market Status
4.9 HeartWare International, Inc. (USA)
4.9.1 HeartWare International, Inc. (USA) Profiles
4.9.2 HeartWare International, Inc. (USA) Product Information
4.9.3 HeartWare International, Inc. (USA) Artificial Liver Business Performance
4.9.4 HeartWare International, Inc. (USA) Artificial Liver Business Development and Market Status
4.10 Jarvik Heart, Inc. (USA)
4.10.1 Jarvik Heart, Inc. (USA) Profiles
4.10.2 Jarvik Heart, Inc. (USA) Product Information
4.10.3 Jarvik Heart, Inc. (USA) Artificial Liver Business Performance
4.10.4 Jarvik Heart, Inc. (USA) Artificial Liver Business Development and Market Status
4.11 Nikkiso Co., Ltd. (Japan)
4.12 Nipro Corporation (Japan)
4.13 SynCardia Systems, Inc. (USA)
4.14 Terumo Heart, Inc. (USA)
4.15 Thoratec Corp. (USA)
4.16 Toray Medical Co., Ltd. (Japan)
5 Market Performance for Manufacturers
5.1 Global Artificial Liver Sales (K Units) and Market Share by Manufacturers 2014-2019
5.2 Global Artificial Liver Revenue (M USD) and Market Share by Manufacturers 2014-2019
5.3 Global Artificial Liver Price (USD/Unit) of Manufacturers 2014-2019
5.4 Global Artificial Liver Gross Margin of Manufacturers 2014-2019
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 North America Market Performance for Manufacturers
6.1.1 North America Artificial Liver Sales (K Units) and Share of Manufacturers 2014-2019
6.1.2 North America Artificial Liver Revenue (M USD) and Share of Manufacturers 2014-2019
6.1.3 North America Artificial Liver Price (USD/Unit) of Manufacturers 2014-2019
6.1.4 North America Artificial Liver Gross Margin of Manufacturers 2014-2019
6.1.5 Market Concentration
6.2 Europe Market Performance for Manufacturers
6.2.1 Europe Artificial Liver Sales (K Units) and Share of Manufacturers 2014-2019
6.2.2 Europe Artificial Liver Revenue (M USD) and Share of Manufacturers 2014-2019
6.2.3 Europe Artificial Liver Price (USD/Unit) of Manufacturers 2014-2019
6.2.4 Europe Artificial Liver Gross Margin of Manufacturers 2014-2019
6.2.5 Market Concentration
6.3 Asia-Pacific Market Performance for Manufacturers
6.3.1 Asia-Pacific Artificial Liver Sales (K Units) and Share of Manufacturers 2014-2019
6.3.2 Asia-Pacific Artificial Liver Revenue (M USD) and Share of Manufacturers 2014-2019
6.3.3 Asia-Pacific Artificial Liver Price (USD/Unit) of Manufacturers 2014-2019
6.3.4 Asia-Pacific Artificial Liver Gross Margin of Manufacturers 2014-2019
6.3.5 Market Concentration
6.4 South America Market Performance for Manufacturers
6.4.1 South America Artificial Liver Sales (K Units) and Share of Manufacturers 2014-2019
6.4.2 South America Artificial Liver Revenue (M USD) and Share of Manufacturers 2014-2019
6.4.3 South America Artificial Liver Price (USD/Unit) of Manufacturers 2014-2019
6.4.4 South America Artificial Liver Gross Margin of Manufacturers 2014-2019
6.4.5 Market Concentration
6.5 Middle East and Africa Market Performance for Manufacturers
6.5.1 Middle East and Africa Artificial Liver Sales (K Units) and Share of Manufacturers 2014-2019
6.5.2 Middle East and Africa Artificial Liver Revenue (M USD) and Share of Manufacturers 2014-2019
6.5.3 Middle East and Africa Artificial Liver Price (USD/Unit) of Manufacturers 2014-2019
6.5.4 Middle East and Africa Artificial Liver Gross Margin of Manufacturers 2014-2019
6.5.5 Market Concentration
7 World Market Performance Point
7.1 World Artificial Liver Sales (K Units) and Share by Regions and Countries 2014-2019
7.1.1 World Artificial Liver Sales (K Units) and Share by Regions 2014-2019
7.1.2 Regional Sales (K Units) and Share by Countries 2014-2019
7.1.2.1 Asia-Pacific Artificial Liver Sales (K Units) and Share by Countries 2014-2019
7.1.2.2 North America Artificial Liver Sales (K Units) and Share by Countries 2014-2019
7.1.2.3 Europe Artificial Liver Sales (K Units) and Share by Countries 2014-2019
7.1.2.4 South America Artificial Liver Sales (K Units) and Share by Countries 2014-2019
7.1.2.5 Middle East and Africa Artificial Liver Sales (K Units) and Share by Countries 2014-2019
7.2 World Revenue (M USD) and Share by Regions and Countries 2014-2019
7.2.1 World Revenue (M USD) and Share by Regions 2014-2019
7.2.2 Regional Revenue (M USD) and Share by Countries 2014-2019
7.2.2.1 Asia-Pacific Artificial Liver Revenue (M USD) and Share by Countries 2014-2019
7.2.2.2 North America Artificial Liver Revenue (M USD) and Share by Countries 2014-2019
7.2.2.3 Europe Artificial Liver Revenue (M USD) and Share by Countries 2014-2019
7.2.2.4 South America Artificial Liver Revenue (M USD) and Share by Countries 2014-2019
7.2.2.5 Middle East and Africa Artificial Liver Revenue (M USD) and Share by Countries 2014-2019
7.3 World Price (USD/Unit) by Regions and Countries 2014-2019
7.3.1 World Price (USD/Unit) by Regions 2014-2019
7.3.2 Regional Price (USD/Unit) by Countries 2014-2019
7.3.2.1 Asia-Pacific Artificial Liver Price (USD/Unit) by Countries 2014-2019
7.3.2.2 North America Artificial Liver Price (USD/Unit) by Countries 2014-2019
7.3.2.3 Europe Artificial Liver Price (USD/Unit) by Countries 2014-2019
7.3.2.4 South America Artificial Liver Price (USD/Unit) by Countries 2014-2019
7.3.2.5 Middle East and Africa Artificial Liver Price (USD/Unit) by Countries 2014-2019
7.4 World Gross Margin by Regions and Countries 2014-2019
7.4.1 World Gross Margin by Regions 2014-2019
7.4.2 Regional Gross Margin and Share by Countries 2014-2019
7.4.2.1 Asia-Pacific Artificial Liver Gross Margin and Share by Countries 2014-2019
7.4.2.2 North America Artificial Liver Gross Margin and Share by Countries 2014-2019
7.4.2.3 Europe Artificial Liver Gross Margin and Share by Countries 2014-2019
7.4.2.4 South America Artificial Liver Gross Margin and Share by Countries 2014-2019
7.4.2.5 Middle East and Africa Artificial Liver Gross Margin and Share by Countries 2014-2019
8 Development Trend for Regions and Countries (Sales Point)
8.1 World Artificial Liver Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.2 Asia-Pacific Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.2.1 China Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.2.2 Japan Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.2.3 Korea Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.2.4 India Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.2.5 Southeast Asia Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.3 North America Artificial Liver Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.3.1 United States Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.3.2 Canada Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.3.3 Mexico Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.4 Europe Artificial Liver Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.4.1 Germany Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.4.2 UK Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.4.3 France Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.4.4 Russia Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.4.5 Italy Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.5 South America Artificial Liver Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.5.1 Brazil Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.5.2 Argentina Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.5.3 Columbia Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.6 Middle East and Africa Artificial Liver Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.6.1 Saudi Arabia Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.6.2 UAE Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.6.3 Egypt Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.6.4 Nigeria Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.6.5 South Africa Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Distributors
11 Consumer Analysis
11.1 Application 1 Industry
11.2 Application 2 Industry
11.3 Application 3 Industry
12 Market Forecast 2020-2026
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2020-2026
12.1.1 Global Artificial Liver Sales (K Units), Revenue (M USD) and Market Share by Regions 2020-2026
12.1.2 Global Artificial Liver Sales (K Units) and Growth Rate 2020-2026
12.1.3 Asia-Pacific Artificial Liver Sales (K Units), Revenue (M USD) and Growth Rate 2020-2026
12.1.4 North America Artificial Liver Sales (K Units), Revenue (M USD) and Growth Rate 2020-2026
12.1.5 Europe Artificial Liver Sales (K Units), Revenue (M USD) and Growth Rate 2020-2026
12.1.6 South America Artificial Liver Sales (K Units), Revenue (M USD) and Growth Rate 2020-2026
12.1.7 Middle East and Africa Artificial Liver Sales (K Units), Revenue (M USD) and Growth Rate 2020-2026
12.2 World Artificial Liver Sales (K Units) and Revenue (M USD) Forecast by Types 2020-2026
12.2.1 Overall Market Performance
12.2.2 Type I Sales (K Units), Revenue (M USD) and Growth Rate 2020-2026
12.2.3 Type II Sales (K Units), Revenue (M USD) and Growth Rate 2020-2026
12.2.4 Type III Sales (K Units), Revenue (M USD) and Growth Rate 2020-2026
12.3 World Artificial Liver Market Forecast by Application 2020-2026
12.3.1 Overall Market Performance
12.3.2 Application 1 Sales and and Growth Rate 2020-2026
12.3.3 Application 2 Sales and and Growth Rate 2020-2026
12.3.4 Application 3 Sales and and Growth Rate 2020-2026
12.4 Price (USD/Unit) and Gross Profit Forecast
12.4.1 Global Artificial Liver Price (USD/Unit) Trend 2020-2026
12.4.2 Global Artificial Liver Gross Profit Trend 2020-2026
13 Conclusion